A secondary analysis presented at the American Stroke Association’s International Stroke Conference 2020 confirmed the safety of apixaban treatment.
Ticagrelor (Brilinta, AstraZeneca) reduced the risk of stroke and death when taken with aspirin compared with aspirin alone.
Many kidney disease patients with atrial fibrillation are not treated with anticoagulation, increasing their risk of stroke.
Study finds different anticoagulation treatment levels for patients with cognitive problems.
A meta-analysis of 95 studies indicates lower risk of stroke and intracranial hemorrhage.
A massive retrospective study compared several non-vitamin K antagonist oral anticoagulants (NOACs) to warfarin.
Using oral anticoagulants and nonsteroidal anti-inflammatory drugs (NSAIDs) together increases the risk for major bleeding and stroke in patients with atrial fibrillation (AF), according to a new analysis.